Abstract
The present invention provides a method of treating, delaying the onset, delaying progression of, reducing the incidence of or reducing the severity of amyotrophic lateral sclerosis in a subject, the method comprising administering to a subject an agent, which interferes with IgG-A2BG2 expression, IgG-A2BG2 function or IgG-A2BG2 interaction with CD16 in said subject.
| Original language | English |
|---|---|
| Patent number | WO2013084236 |
| IPC | A61P 25/ 28 A I |
| Priority date | 5/12/11 |
| State | Published - 13 Jun 2013 |